These BP reductions are associated with improvements in left ventricular structure and function, as well as peripheral vascular health
That said, some competitors go even further in their quest for safety, though that often comes at the expense of convenience
Public Citizen petitioned the Trump administration to use a federal law to authorize generic competitors for GLP-1 drugs for treating obesity and diabetes, arguing that prices are unjustifiably high for too many Americans

Category Breakdown Digital Platforms providing medication and support with a single focus on weight loss: Found: US / Funding $132M Calibrate : US / Funding $125M Sequence acquired by Weight Watchers: US Weekend Health acquired by Weight Watchers: US Telehealth companies also providing other solutions such as sexual health, mental health, fertility, hair loss, etc: Everly Health : US / Funding $200M Noom: US / Funding $659M Ro : US / Funding $1B One Medical: US / Funding $532M / NASDAQ Virtual Clinics providing clinical consultation, advice and treatment planning: FormHealth : US / Funding $26.3M Fella : US / Funding N/A Enara : US / Funding $9M Alfie : US / Funding N/A Knownwel: US / Funding $4.5M Accomplish Health: US / Funding N/A Companies focusing on CGM, Metabolic Health and others ways of weight Management : Signos : US / Funding $17M Oviva : US / Funding $113M Equip : US / Funding $75M Limbo : US / Funding $6M Viome: US / Funding $169.5M Heal Club : US / Funding N/A Nextmed : US / Funding N/A Ilant Health : US / Funding N/A Virta: US / Funding $373M Fruit Street : US / Funding $15.5M Intelli health: US / Funding N/A Barclays' valuation call stands as one of the most audacious for the industry, with Citi Pharmaceuticals estimating a $50 billion valuation by 2030, and Morgan Stanley similarly projecting a $54 billion valuation by 2030 in a research note from last August
